Federal contract award

75F40122C00170

TIME AND MATERIAL AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) - OFFICE OF COMPLIANCE (OC) - OMQ E-LEARNING TOOLS SUPPORT COR: MARK AGNELLO MARK.AGNELLO@FDA.HHS.GOV TECHNICAL POC: PAUL BALCER PAUL.BALCER@FDA.HHS.GOV

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS611430 — Professional and Management Development Training
PSCU009 — Education Services
Parent award / vehicleNot reported
Set-aside8(A) SOLE SOURCE
Pricing typeFIRM FIXED PRICE
Obligations$572.0K
Current contract value$572.0K
Potential contract value / ceiling$572.0K
Start dateSep 15, 2022
Current end dateMay 31, 2025
Potential end dateFeb 28, 2026
Latest award activityMay 28, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 28, 2026P00008$-4TIME AND MATERIAL AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) - OFFICE OF COMPLIANCE (OC) - OMQ E-LEARNING TOOLS SUPPORT COR: OLIN BAKKE OLIN.BAKKE@FDA.HHS.GOV CS: KIMBERLY W. DAVIS KIMBERLY.DAVIS@FDA.HHS.GOV
Feb 28, 2025P00007$0TIME AND MATERIAL AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) - OFFICE OF COMPLIANCE (OC) - OMQ E-LEARNING TOOLS SUPPORT COR: OLIN BAKKE OLIN.BAKKE@FDA.HHS.GOV CS: KIMBERLY W. DAVIS KIMBERLY.DAVIS@FDA.HHS.GOV
Feb 20, 2025P00006$0TIME AND MATERIAL AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) - OFFICE OF COMPLIANCE (OC) - OMQ E-LEARNING TOOLS SUPPORT COR: OLIN BAKKE OLIN.BAKKE@FDA.HHS.GOV CS: KIMBERLY W. DAVIS KIMBERLY.DAVIS@FDA.HHS.GOV

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.